When should we delay highly active antiretroviral therapy?
- David R. BangsbergAffiliated withEpidemiology and Prevention Intervention Center, San Francisco General Hospital
- , Andrew MossAffiliated withDepartment of Epidemiology and Biostatistics, University of California
- When should we delay highly active antiretroviral therapy?
Journal of General Internal Medicine
Volume 14, Issue 7 , pp 446-448
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors